Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,362 public trials 202 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Completed

A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389

NCT06812780

Conditions
Digestive System Diseases, Fibrosis, Hemic and Lymphatic Diseases, +14 more
Locations
  • Research Site Chandler, Arizona, United States
  • Research Site Rialto, California, United States
  • Research Site Miami Lakes, Florida, United States
  • Research Site Orlando, Florida, United States
View Trial Details
Completed

BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)

NCT04018248

Conditions
B Cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +36 more
Locations
  • Henry Ford Hospital Detroit, Michigan, United States
  • National Cancer Center Goyang-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Chonnam National University Hwasun Hospital Hwasun, Jeollanam-do, South Korea
View Trial Details
Completed

Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

NCT00278408

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +21 more
Locations
  • Rigshospitalet, Department of Hematology Copenhagen, Denmark
  • Amtssygehuset i Herlev Herlev, Denmark
  • GMP Tummes/Weinberg Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
View all 152 locations
View Trial Details
Completed

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)

NCT03424122

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • University of Arizona Cancer Center - Out Pt. Tucson, Arizona, United States
  • Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States
  • Comprehensive Cancer Center of Nevada Las Vegas, Nevada, United States
  • Texas Oncology Austin, Texas, United States
View all 21 locations
View Trial Details
Completed

Study Evaluating Safety and Efficacy of INCB050465 Combined With Bendamustine and Obinutuzumab in Relapsed or Refractory Follicular Lymphoma (CITADEL-102)

NCT03039114

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • University of California, San Diego La Jolla, California, United States
  • University of Kansas Cancer Center Fairway, Kansas, United States
  • Center for Cancer and Blood Disorders (CCBD) - Bethesda Bethesda, Maryland, United States
View all 21 locations
View Trial Details

Related conditions